$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia 원문보기

American journal of human genetics, v.100 no.3, 2017년, pp.454 - 472  

Lim, J.S. ,  Gopalappa, R. ,  Kim, S.H. ,  Ramakrishna, S. ,  Lee, M. ,  Kim, W.i. ,  Kim, J. ,  Park, S.M. ,  Lee, J. ,  Oh, J.H. ,  Kim, H.D. ,  Park, C.H. ,  Lee, J.S. ,  Kim, S. ,  Kim, D.S. ,  Han, J.M. ,  Kang, H.C. ,  Kim, H.(. ,  Lee, J.H.

Abstract AI-Helper 아이콘AI-Helper

Focal cortical dysplasia (FCD) is a major cause of the sporadic form of intractable focal epilepsies that require surgical treatment. It has recently been reported that brain somatic mutations in MTOR account for 15%-25% of FCD type II (FCDII), characterized by cortical dyslamination and dysmorphic ...

주제어

참고문헌 (70)

  1. Epileptic Disord. Blumcke 11 181 2009 Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia 

  2. Brain Sisodiya 123 1075 2000 10.1093/brain/123.6.1075 Surgery for malformations of cortical development causing epilepsy 

  3. Acta Neurol. Scand. Bast 113 72 2006 10.1111/j.1600-0404.2005.00555.x Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults 

  4. Brain Tassi 125 1719 2002 10.1093/brain/awf175 Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome 

  5. Brain Fauser 129 1907 2006 10.1093/brain/awl133 Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients 

  6. Brain Fauser 127 2406 2004 10.1093/brain/awh277 Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology 

  7. J. Biol. Chem. Zech 291 20008 2016 10.1074/jbc.M116.732446 Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis 

  8. Nat. Med. Lim 21 395 2015 10.1038/nm.3824 Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy 

  9. Ann. Neurol. Nakashima 78 375 2015 10.1002/ana.24444 Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb 

  10. Nat. Neurosci. Costa-Mattioli 16 1537 2013 10.1038/nn.3546 mTOR complexes in neurodevelopmental and neuropsychiatric disorders 

  11. Wong 2012 SourceJasper’s Basic Mechanisms of the Epilepsies 

  12. Cell Laplante 149 274 2012 10.1016/j.cell.2012.03.017 mTOR signaling in growth control and disease 

  13. Acta Neuropathol. Aronica 114 287 2007 10.1007/s00401-007-0225-6 Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly 

  14. Ann. Neurol. Baybis 56 478 2004 10.1002/ana.20211 mTOR cascade activation distinguishes tubers from focal cortical dysplasia 

  15. Ann. Neurol. Ljungberg 60 420 2006 10.1002/ana.20949 Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia 

  16. Ann. Neurol. Miyata 56 510 2004 10.1002/ana.20234 Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis 

  17. Ann. Neurol. D’Gama 77 720 2015 10.1002/ana.24357 Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia 

  18. Nat. Genet. Inoki 37 19 2005 10.1038/ng1494 Dysregulation of the TSC-mTOR pathway in human disease 

  19. Nat. Genet. Lee 44 941 2012 10.1038/ng.2329 De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly 

  20. Hum. Genet. Qin 127 573 2010 10.1007/s00439-010-0801-z Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex 

  21. PLoS Genet. Tyburczy 11 e1005637 2015 10.1371/journal.pgen.1005637 Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing 

  22. J. Clin. Invest. Feliciano 121 1596 2011 10.1172/JCI44909 Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice 

  23. Science Doudna 346 1258096 2014 10.1126/science.1258096 Genome editing. The new frontier of genome engineering with CRISPR-Cas9 

  24. Nat. Rev. Genet. Kim 15 321 2014 10.1038/nrg3686 A guide to genome engineering with programmable nucleases 

  25. Epilepsia Blumcke 52 158 2011 10.1111/j.1528-1167.2010.02777.x The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission 

  26. Epilepsia Kim 52 722 2011 10.1111/j.1528-1167.2010.02950.x Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery 

  27. Pediatr. Neurol. Northrup 49 243 2013 10.1016/j.pediatrneurol.2013.08.001 Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference 

  28. N. Engl. J. Med. Shirley 368 1971 2013 10.1056/NEJMoa1213507 Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ 

  29. Genome Biol. Kuilman 16 49 2015 10.1186/s13059-015-0617-1 CopywriteR: DNA copy number detection from off-target sequence data 

  30. Science Cong 339 819 2013 10.1126/science.1231143 Multiplex genome engineering using CRISPR/Cas systems 

  31. Genome Res. Ramakrishna 24 1020 2014 10.1101/gr.171264.113 Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA 

  32. Genome Res. Kim 19 1279 2009 10.1101/gr.089417.108 Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly 

  33. Methods Kim 69 108 2014 10.1016/j.ymeth.2014.04.012 Enrichment of cells with TALEN-induced mutations using surrogate reporters 

  34. Methods Mol. Biol. Guschin 649 247 2010 10.1007/978-1-60761-753-2_15 A rapid and general assay for monitoring endogenous gene modification 

  35. Nat. Commun. Ramakrishna 5 3378 2014 10.1038/ncomms4378 Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations 

  36. Cell Rep. Renaud 14 2263 2016 10.1016/j.celrep.2016.02.018 Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases 

  37. Genet. Med. Au 9 88 2007 10.1097/GIM.0b013e31803068c7 Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States 

  38. Bioinformatics Saunders 28 1811 2012 10.1093/bioinformatics/bts271 Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs 

  39. PLoS ONE Ratan 8 e55089 2013 10.1371/journal.pone.0055089 Comparison of sequencing platforms for single nucleotide variant calls in a human sample 

  40. Nat. Biotechnol. Lam 30 78 2011 10.1038/nbt.2065 Performance comparison of whole-genome sequencing platforms 

  41. Nat. Genet. Lin 46 866 2014 10.1038/ng.3006 The genomic landscape of nasopharyngeal carcinoma 

  42. Biochem. J. Huang 412 179 2008 10.1042/BJ20080281 The TSC1-TSC2 complex: a molecular switchboard controlling cell growth 

  43. Oncogene Benvenuto 19 6306 2000 10.1038/sj.onc.1204009 The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination 

  44. J. Biol. Chem. Chong-Kopera 281 8313 2006 10.1074/jbc.C500451200 TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase 

  45. Mol. Cell. Biol. Li 24 7965 2004 10.1128/MCB.24.18.7965-7975.2004 Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity 

  46. Nat. Commun. Lozovaya 5 4563 2014 10.1038/ncomms5563 Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model 

  47. Eur. J. Hum. Genet. Sancak 13 731 2005 10.1038/sj.ejhg.5201402 Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex 

  48. Epilepsy Curr. Wong 15 129 2015 10.5698/1535-7597-15.3.129 Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy 

  49. Hum. Mutat. Hoogeveen-Westerveld 33 476 2012 10.1002/humu.22007 Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex 

  50. BMC Med. Genet. Mozaffari 10 88 2009 10.1186/1471-2350-10-88 Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex 

  51. Dis. Model. Mech. Magri 6 1185 2013 10.1242/dmm.012096 Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models 

  52. J. Clin. Invest. Zhang 112 1223 2003 10.1172/JCI200317222 Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR 

  53. Cell Mikuni 165 1803 2016 10.1016/j.cell.2016.04.044 High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing 

  54. Nat. Protoc. Ran 8 2281 2013 10.1038/nprot.2013.143 Genome engineering using the CRISPR-Cas9 system 

  55. N. Engl. J. Med. Jamuar 371 733 2014 10.1056/NEJMoa1314432 Somatic mutations in cerebral cortical malformations 

  56. Science Poduri 341 1237758 2013 10.1126/science.1237758 Somatic mutation, genomic variation, and neurological disease 

  57. Annu. Rev. Genomics Hum. Genet. Hu 15 195 2014 10.1146/annurev-genom-090413-025600 The diverse genetic landscape of neurodevelopmental disorders 

  58. Genome Biol. Kim 14 R90 2013 10.1186/gb-2013-14-8-r90 Virmid: accurate detection of somatic mutations with sample impurity inference 

  59. Exp. Mol. Med. Lee 48 e239 2016 10.1038/emm.2016.53 Somatic mutations in disorders with disrupted brain connectivity 

  60. Trends Biotechnol. Gaj 31 397 2013 10.1016/j.tibtech.2013.04.004 ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering 

  61. Cell Hsu 157 1262 2014 10.1016/j.cell.2014.05.010 Development and applications of CRISPR-Cas9 for genome engineering 

  62. Nat. Commun. Zuckermann 6 7391 2015 10.1038/ncomms8391 Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling 

  63. PLoS ONE Straub 9 e105584 2014 10.1371/journal.pone.0105584 CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons 

  64. EMBO Rep. Kalebic 17 338 2016 10.15252/embr.201541715 CRISPR/Cas9-induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo 

  65. Nature Lek 536 285 2016 10.1038/nature19057 Analysis of protein-coding genetic variation in 60,706 humans 

  66. Genet. Med. Walsh 2016 Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 

  67. Hum. Mutat. Hoogeveen-Westerveld 32 424 2011 10.1002/humu.21451 Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex 

  68. Ann. Neurol. Baulac 77 675 2015 10.1002/ana.24368 Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations 

  69. Ann. Neurol. Sim 79 132 2016 10.1002/ana.24502 Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3 

  70. Brain Jansen 138 1613 2015 10.1093/brain/awv045 PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia 

LOADING...

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로